REGISTERED NUMBER: 11219653 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Gemini Genetics Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

T R V Matson

Mrs K A Ashmore

REGISTERED OFFICE:

International House

6 Market Street

Oakengates

Telford

Shropshire

TF2 6EF

REGISTERED NUMBER:

11219653 (England and Wales)

ACCOUNTANTS:

Tranter Lowe (Oakengates) Limited

Chartered Accountants

International House

6 Market Street

Oakengates

Telford

Shropshire

TF2 6EF

FIXED ASSETS

Tangible assets

4

25,199

28,215

CURRENT ASSETS

Debtors

5

35,361

30,061

Cash at bank and in hand

93,171

50,046

128,532

80,107

CREDITORS

Amounts falling due within one year

6

29,903

19,393

NET CURRENT ASSETS

98,629

60,714

TOTAL ASSETS LESS CURRENT LIABILITIES

123,828

88,929

PROVISIONS FOR LIABILITIES

6,322

7,477

NET ASSETS

117,506

81,452

CAPITAL AND RESERVES

Called up share capital

208

208

Retained earnings

117,298

81,244

117,506

81,452

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 December 2025 and were signed on its behalf by:

T R V Matson - Director

1.	STATUTORY INFORMATION

Gemini Genetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

20% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Computer

machinery

fittings

equipment

Totals

£

£

£

£

COST

At 1 April 2024

32,558

2,379

5,561

40,498

Additions

995

-

4,060

5,055

At 31 March 2025

33,553

2,379

9,621

45,553

DEPRECIATION

At 1 April 2024

9,099

1,376

1,808

12,283

Charge for year

4,980

200

2,891

8,071

At 31 March 2025

14,079

1,576

4,699

20,354

NET BOOK VALUE

At 31 March 2025

19,474

803

4,922

25,199

At 31 March 2024

23,459

1,003

3,753

28,215

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

14,742

9,442

Other debtors

208

208

Owed by associated company

20,411

20,411

35,361

30,061

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade creditors

756

5,725

Amounts owed to group undertakings

6,000

6,000

Tax

14,714

3,777

VAT

5,768

1,801

Accrued expenses

2,665

2,090

29,903

19,393

7.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Matson Holdings Limited.